Most clinical trials are still conducted through having participants attend a research site.

And there are often good reasons for this – including such things as having the necessary equipment available, and being able to ensure the integrity of the data collected.

From a patient recruitment perspective, this does somewhat limit the potential patient pool, with only people within a realistic traveling distance of a relevant site likely being interested in taking part.

There are ways to get round this issue through such methods as providing transport and accommodation options for people who might live a distance away from a site.

And, obviously, the whole concept of Decentralized Trials is based on the idea of not operating the trial solely from research sites.

What will work best for patients, of course, is being able to offer them the choice of how they participate – thus helping recruit more people in the first place.

You may also like

Any Idiot can do Patient Recruitment
I was chatting with a fellow patient recruitment specialist recently, and he used the phrase ‘any idiot can do patient recruitment’. I won’t reel off the list of names that came into my head ...
Decentralized Trials Have been Downplayed Recently
It’s been interesting to see the downplaying of the phrase DCT - Decentralized Trials – within the industry over the last few years. Starting with the COVID pandemic, for the next two or ...
Thoughts on the 2025 SCOPE Summit day three
One of the highlights that stands out to me for today’s SCOPE Summit is the special book signing during the morning coffee break. I did my own signing in the same slot at last year’s event, ...